1.06
price up icon0.95%   0.01
after-market Dopo l'orario di chiusura: 1.09 0.03 +2.83%
loading
Precedente Chiudi:
$1.05
Aprire:
$1.08
Volume 24 ore:
1.59M
Relative Volume:
0.33
Capitalizzazione di mercato:
$86.75M
Reddito:
-
Utile/perdita netta:
$-117.23M
Rapporto P/E:
-0.7361
EPS:
-1.44
Flusso di cassa netto:
$-95.25M
1 W Prestazione:
-15.87%
1M Prestazione:
-26.90%
6M Prestazione:
-71.51%
1 anno Prestazione:
-75.58%
Intervallo 1D:
Value
$1.04
$1.12
Intervallo di 1 settimana:
Value
$1.04
$1.28
Portata 52W:
Value
$0.9867
$7.01

Tenaya Therapeutics Inc Stock (TNYA) Company Profile

Name
Nome
Tenaya Therapeutics Inc
Name
Telefono
415-865-2066
Name
Indirizzo
171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO
Name
Dipendente
140
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
TNYA's Discussions on Twitter

Confronta TNYA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
TNYA
Tenaya Therapeutics Inc
1.06 86.75M 0 -117.23M -95.25M -1.44
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
438.40 113.67B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
683.08 74.97B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
665.68 40.50B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
277.16 35.95B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
120.88 29.63B 3.30B -501.07M 1.03B -2.1146

Tenaya Therapeutics Inc Stock (TNYA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-06-10 Iniziato William Blair Outperform
2023-11-30 Iniziato Leerink Partners Outperform
2022-06-15 Iniziato H.C. Wainwright Buy

Tenaya Therapeutics Inc Borsa (TNYA) Ultime notizie

pulisher
Jan 29, 2025

Tenaya Therapeutics announces option repricing to retain staff - Investing.com

Jan 29, 2025
pulisher
Jan 23, 2025

Here's Why Tenaya Therapeutics (NASDAQ:TNYA) Must Use Its Cash Wisely - Simply Wall St

Jan 23, 2025
pulisher
Jan 22, 2025

Tenaya Therapeutics (TNYA) Stock Price, News & Analysis - MarketBeat

Jan 22, 2025
pulisher
Jan 16, 2025

Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Shares Sold by Jane Street Group LLC - Defense World

Jan 16, 2025
pulisher
Jan 16, 2025

Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives $17.33 Average PT from Brokerages - MarketBeat

Jan 16, 2025
pulisher
Jan 16, 2025

Brokerages Set Tenaya Therapeutics, Inc. (NASDAQ:TNYA) PT at $17.33 - Defense World

Jan 16, 2025
pulisher
Jan 15, 2025

Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Short Interest Update - MarketBeat

Jan 15, 2025
pulisher
Jan 14, 2025

HC Wainwright Reiterates Buy Rating for Tenaya Therapeutics (NASDAQ:TNYA) - MarketBeat

Jan 14, 2025
pulisher
Jan 13, 2025

Tenaya advances gene therapies for heart conditions By Investing.com - Investing.com Canada

Jan 13, 2025
pulisher
Jan 13, 2025

Tenaya Therapeutics Announces 2025 Strategic Priorities and Anticipated Milestones - GlobeNewswire

Jan 13, 2025
pulisher
Jan 13, 2025

Tenaya advances gene therapies for heart conditions - Investing.com

Jan 13, 2025
pulisher
Jan 13, 2025

Tenaya Therapeutics Advances Gene Therapy Programs with Promising TN-201 Trial Progress - StockTitan

Jan 13, 2025
pulisher
Jan 13, 2025

Analysts Set Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Price Target at $17.33 - MarketBeat

Jan 13, 2025
pulisher
Jan 08, 2025

Geode Capital Management LLC Increases Holdings in Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World

Jan 08, 2025
pulisher
Jan 03, 2025

Things To Consider Before Buying Tenaya Therapeutics Inc (NASDAQ: TNYA) - Stocks Register

Jan 03, 2025
pulisher
Jan 03, 2025

Zhongzhi drops $3M in Gabaeron series A for stem cell AD therapy - BioWorld Online

Jan 03, 2025
pulisher
Jan 02, 2025

Largest borrow rate increases among liquid names - TipRanks

Jan 02, 2025
pulisher
Jan 02, 2025

State Street Corp Purchases 9,506 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World

Jan 02, 2025
pulisher
Dec 30, 2024

Tenaya Therapeutics: TN-201 Isn't The Only Shot On Goal Targeting Heart Disease (TNYA) - Seeking Alpha

Dec 30, 2024
pulisher
Dec 29, 2024

Short Interest in Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Grows By 18.8% - MarketBeat

Dec 29, 2024
pulisher
Dec 24, 2024

Reviewing Caribou Biosciences (NASDAQ:CRBU) & Tenaya Therapeutics (NASDAQ:TNYA) - Defense World

Dec 24, 2024
pulisher
Dec 22, 2024

XTX Topco Ltd Has $95,000 Position in Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World

Dec 22, 2024
pulisher
Dec 20, 2024

Tenaya Therapeutics (NASDAQ:TNYA) Earns Buy Rating from Chardan Capital - Defense World

Dec 20, 2024
pulisher
Dec 20, 2024

Tenaya Therapeutics (NASDAQ:TNYA) Earns “Buy” Rating from HC Wainwright - Defense World

Dec 20, 2024
pulisher
Dec 19, 2024

Tenaya Therapeutics (NASDAQ: TNYA) Senior Vice President Chihiro Saito Resigns: 8-K Filing - Defense World

Dec 19, 2024
pulisher
Dec 18, 2024

Tenaya Therapeutics stock backed by H.C. Wainwright on TN-401 safety and protein expression gains - Investing.com

Dec 18, 2024
pulisher
Dec 18, 2024

Tenaya Therapeutics (NASDAQ:TNYA) Receives "Buy" Rating from Chardan Capital - MarketBeat

Dec 18, 2024
pulisher
Dec 18, 2024

Tenaya Therapeutics (NASDAQ:TNYA) Given "Buy" Rating at HC Wainwright - MarketBeat

Dec 18, 2024
pulisher
Dec 18, 2024

Tenaya Stock Crashes as Cardio Gene Therapy Delivers Underwhelming Early-Stage Data - BioSpace

Dec 18, 2024
pulisher
Dec 18, 2024

Tenaya Therapeutics stock hits 52-week low at $1.49 By Investing.com - Investing.com South Africa

Dec 18, 2024
pulisher
Dec 18, 2024

Contrasting Tenaya Therapeutics (NASDAQ:TNYA) and Vaxart (NASDAQ:VXRT) - Defense World

Dec 18, 2024
pulisher
Dec 17, 2024

Tenaya Therapeutics (NASDAQ:TNYA) & Big Cypress Acquisition (OTCMKTS:BCYP) Critical Comparison - Defense World

Dec 17, 2024
pulisher
Dec 17, 2024

Tenaya reports positive early data on heart gene therapy By Investing.com - Investing.com Australia

Dec 17, 2024
pulisher
Dec 17, 2024

Tenaya stock in selloff on gene therapy data (TNYA:NASDAQ) - Seeking Alpha

Dec 17, 2024
pulisher
Dec 17, 2024

Tenaya Therapeutics announces executive departure - Investing.com

Dec 17, 2024
pulisher
Dec 17, 2024

Tenaya Therapeutics stock hits 52-week low at $1.49 - Investing.com

Dec 17, 2024
pulisher
Dec 17, 2024

Tenaya Therapeutics Reports Promising TN-201 Trial Results - TipRanks

Dec 17, 2024
pulisher
Dec 17, 2024

Tenaya Therapeutics’ Senior VP Resigns for New Opportunity - TipRanks

Dec 17, 2024
pulisher
Dec 17, 2024

Tenaya reports positive early data on heart gene therapy - Investing.com

Dec 17, 2024
pulisher
Dec 17, 2024

Tenaya Therapeutics Reports Promising Early Data from MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 for Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy - GlobeNewswire

Dec 17, 2024
pulisher
Dec 17, 2024

Tenaya's Gene Therapy Shows Promise in Early Heart Disease Trial DataKey Clinical Results - StockTitan

Dec 17, 2024
pulisher
Dec 17, 2024

Crude Oil Down Over 1%; US Industrial Production Declines In November - Benzinga

Dec 17, 2024
pulisher
Dec 16, 2024

Tenaya Therapeutics to Announce Initial Data from MyPEAK-1 Phase 1b/2 Clinical Trial of TN-201 Gene Therapy for MYBPC3-Associated Hypertrophic Cardiomyopathy on Tuesday, December 17, 2024 - The Manila Times

Dec 16, 2024
pulisher
Dec 16, 2024

Tenaya Therapeutics to Unveil Groundbreaking Gene Therapy Data for Heart Disease Treatment - StockTitan

Dec 16, 2024
pulisher
Dec 16, 2024

Tenaya Therapeutics to Announce Initial Data from MyPEAK-1 - GlobeNewswire

Dec 16, 2024
pulisher
Dec 15, 2024

Fmr LLC Raises Stock Holdings in Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World

Dec 15, 2024
pulisher
Dec 11, 2024

Around the Helix: Cell and Gene Therapy Company Updates – December 11, 2024 - CGTLive™

Dec 11, 2024
pulisher
Dec 10, 2024

Tenaya Therapeutics' SWOT analysis: gene therapy stock faces pivotal catalysts - Investing.com

Dec 10, 2024

Tenaya Therapeutics Inc Azioni (TNYA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$352.30
price down icon 5.49%
$41.04
price up icon 0.79%
$22.36
price up icon 3.33%
$5.41
price up icon 3.84%
biotechnology ONC
$226.89
price up icon 0.08%
$120.88
price down icon 0.23%
Capitalizzazione:     |  Volume (24 ore):